Kit Opi Rgt DRI 3x18mL

SKU
TF-10014601
The DRI Opiate Assay is a homogeneous enzyme immunoassay intended for the qualitative or semi-quantitative determination of opiates in human urine with 300 ng/mL or 2000 ng/mL as a cutoff calibrator
Request a Quote
More Information
Assay Features • Qualitative or semi-quantitative options for results
• Excellent correlation to GC/MS
• Variety of calibrators and multiconstituent control sets
The DRI®Opiate Assay is a homogeneous enzyme immunoassay3 using ready-to-use liquid reagents. The assay uses monoclonal antibodies that detect opiates in urine. The assay is based on the competition between an enzyme glucose-6-phosphate dehydrogenase (G6PDH) labeled drug and the free drug from the urine sample for a fixed amount of specific antibody binding sites. In the absence of free drug from the sample, the specific antibody binds the drug-labeled G6PDH and the enzyme activity is inhibited. This phenomenon creates a direct relationship between drug concentration in urine and the enzyme activity. The enzyme G6PDH activity is determined spectrophotometrically at 340 nm by measuring its ability to convert nicotinamide adenine dinucleotide (NAD) to NADH.
© 2020 Cliawaived, Inc. All Rights Reserved. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.